The role of PKR/eIF2α signaling pathway in prognosis of Non-Small cell lung cancer

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  He, Yong ^a,b   Correa, Arlene M ^b   Raso, Maria Gabriela ^b   Hofstetter, Wayne L ^b   Fang, Bingliang ^b   Behrens, Carmen ^b   Roth, Jack A ^b   Zhou, Yihong ^c   Yu, Liping ^d   Wistuba, Ignacio I ^b   Swisher, Stephen G ^b   Pataer, Apar ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Ziren Research LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INITIATION FACTOR 2ALPHA; MESSENGER RNA; PROTEIN KINASE; INITIATION FACTOR 2; PROTEIN KINASE R;

ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; WESTERN BLOTTING; ADENOCARCINOMA; ENZYME IMMUNOASSAY; GENETICS; LUNG TUMOR; METABOLISM; MORTALITY; PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ADENOCARCINOMA; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; EIF-2 KINASE; EUKARYOTIC INITIATION FACTOR-2; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MALE; PHOSPHORYLATION; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SURVIVAL RATE;

EID: 80755143201     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024855     Document Type: Article

References (23)

1. Pataer A, Raso MG, Correa AM, Behrens C, Tsuta K, et al. (2010) RNA-dependent protein kinase is an independent prognostic variable for non-small cell lung cancer patients. Clin Cancer Res 16: 5522-5528.
2. Haines GK 3rd, Becker S, Ghadge G, Kies M, Pelzer H, et al. (1993) Expression of the double-stranded RNA-dependent protein kinase (p68) in squamous cell carcinoma of the head and neck region. Arch Otolaryngol Head Neck Surg 119: 1142-1147.
3. Singh C, Haines GK, Talamonti MS, Radosevich JA, (1995) Expression of p68 in human colon cancer. Tumour Biol 16: 281-289.
4. Li S, Koromilas AE, (2001) Dominant negative function by an alternatively spliced form of the interferon-inducible protein kinase PKR. J Biol Chem 276: 13881-13890.
5. Hii SI, Hardy L, Crough T, Payne EJ, Grimmett K, et al. (2004) Loss of PKR activity in chronic lymphocytic leukemia. Int J Cancer 109: 329-335.
6. Bilanges B, Stokoe D, (2007) Mechanisms of translational deregulation in human tumors and therapeutic intervention strategies. Oncogene 26: 5973-5990.
7. Holland EC, Sonenberg N, Pandolfi PP, Thomas G, (2004) Signaling control of mRNA translation in cancer pathogenesis. Oncogene 23: 3138-3144.
8. Hovanessian AG, (1989) The double stranded RNA-activated protein kinase induced by interferon: dsRNA-PK. J Interferon Res 9: 641-647.
9. Williams BR, (2001) Signal integration via PKR. Sci STKE 2001: re2.
10. Toth AM, Zhang P, Das S, George CX, Samuel CE, (2006) Interferon action and the double-stranded RNA-dependent enzymes ADAR1 adenosine deaminase and PKR protein kinase. Prog Nucleic Acid Res Mol Biol 81: 369-434.
11. Kim SH, Forman AP, Mathews MB, Gunnery S, (2000) Human breast cancer cells contain elevated levels and activity of the protein kinase, PKR. Oncogene 19: 3086-3094.
12. Kim SH, Gunnery S, Choe JK, Mathews MB, (2002) Neoplastic progression in melanoma and colon cancer is associated with increased expression and activity of the interferon-inducible protein kinase, PKR. Oncogene 21: 8741-8748.
13. Schewe DM, Aguirre-Ghiso JA, (2009) Inhibition of eIF2alpha dephosphorylation maximizes bortezomib efficiency and eliminates quiescent multiple myeloma cells surviving proteasome inhibitor therapy. Cancer Res 69: 1545-1552.
14. Zhu K, Chan W, Heymach J, Wilkinson M, McConkey DJ, (2009) Control of HIF-1alpha expression by eIF2 alpha phosphorylation-mediated translational repression. Cancer Res 69: 1836-1843.
15. Mounir Z, Krishnamoorthy JL, Robertson GP, Scheuner D, Kaufman RJ, et al. (2009) Tumor suppression by PTEN requires the activation of the PKR-eIF2alpha phosphorylation pathway. Sci Signal 2: ra85.
16. Shimada A, Shiota G, Miyata H, Kamahora T, Kawasaki H, et al. (1998) Aberrant expression of double-stranded RNA-dependent protein kinase in hepatocytes of chronic hepatitis and differentiated hepatocellular carcinoma. Cancer Res 58: 4434-4438.
17. Vorburger SA, Pataer A, Swisher SG, Hunt KK, (2004) Genetically targeted cancer therapy: tumor destruction by PKR activation. Am J Pharmacogenomics 4: 189-198.
18. Pataer A, Vorburger SA, Barber GN, Chada S, Mhashilkar AM, et al. (2002) Adenoviral transfer of the melanoma differentiation-associated gene 7 (mda7) induces apoptosis of lung cancer cells via up-regulation of the double-stranded RNA-dependent protein kinase (PKR). Cancer Res 62: 2239-2243.
19. D'Acquisto F, Ghosh S, (2001) PACT and PKR: turning on NF-kappa B in the absence of virus. Sci STKE 2001: re1.
20. Hu W, Hofstetter W, Wei X, Guo W, Zhou Y, et al. (2009) Double-stranded RNA-dependent protein kinase-dependent apoptosis induction by a novel small compound. J Pharmacol Exp Ther 328: 866-872.
21. Trisciuoglio D, Uranchimeg B, Cardellina JH, Meragelman TL, Matsunaga S, et al. (2008) Induction of apoptosis in human cancer cells by candidaspongiolide, a novel sponge polyketide. J Natl Cancer Inst 100: 1233-1246.
22. Travis WD, Garg K, Franklin WA, Wistuba II, Sabloff B, et al. (2006) Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria. J Thorac Oncol 1: S13-19.
23. Zhou YH, Hess KR, Liu L, Linskey ME, Yung WK, (2005) Modeling prognosis for patients with malignant astrocytic gliomas: quantifying the expression of multiple genetic markers and clinical variables. Neuro Oncol 7: 485-494.